Assanto ,, G.M. et al. 2023. Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study. Mediterranean Journal of Hematology and Infectious Diseases. 15, 1 (Oct. 2023), e2023061. DOI:https://doi.org/10.4084/MJHID.2023.061.